Eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal

Eli Lilly stock is in a buy zone above a pivot at 1,133.95 ahead of its second-quarter results, due on Aug. 5.

Raccontata dainvestors.com